We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$554M
1-Year Est. Return
29.39%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+29.39%
3 Year Est. Return
+99.7%
5 Year Est. Return
+120.39%
10 Year Est. Return
+406.87%
AUM
$157M
AUM Growth
+$16.9M
(+12%)
Cap. Flow
-$1.8M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
125
New
21
Increased
33
Reduced
32
Closed
9
Top Buys
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$2.26M |
| 2 |
K
Kellanova
K
|
+$924K |
| 3 |
BSJK
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
|
+$887K |
| 4 |
Walt Disney
DIS
|
+$794K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$763K |
Top Sells
| 1 |
CVS Health
CVS
|
+$2.24M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$1.44M |
| 3 |
Fastenal
FAST
|
+$1.4M |
| 4 |
Amazon
AMZN
|
+$1.36M |
| 5 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$1.02M |
Sector Composition
| 1 | Consumer Discretionary | 15.84% |
| 2 | Technology | 12.61% |
| 3 | Communication Services | 11.91% |
| 4 | Healthcare | 8.67% |
| 5 | Consumer Staples | 8.64% |
Similar funds
LFS
TC
SIM
AWA
FFA
CCA
HWM
TPA
Bellecapital's Q1 2019 Portfolio in Review
As of Q1 2019, Bellecapital held 125 positions worth $157M, up 12% from $140M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Bellecapital's Q1 2019 filing shows 21 new, 33 increased, 32 reduced and 9 closed positions. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 43,284 shares worth $2.29M. The largest sale was CVS Health, an estimated $2.24M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 16% a quarter earlier, followed by Technology and Communication Services.
- Bellecapital's largest Q1 2019 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 43,284 shares worth $2.29M.
- Bellecapital added most to Walt Disney in Q1 2019, an estimated $794K increase.
- Bellecapital's biggest Q1 2019 reduction was PRA Health Sciences, Inc., cutting an estimated $1.44M.
- Bellecapital fully exited CVS Health in Q1 2019, selling an estimated $2.24M.
- Bellecapital's ten largest holdings make up 39% of its $157M portfolio in Q1 2019.
- Bellecapital opened 21 new positions and closed 9 in Q1 2019.
- Bellecapital's portfolio value rose 12% quarter-over-quarter to $157M.
Based on Bellecapital's 13F filing for Q1 2019, filed 23 Apr 2019.